Pfmdr1 copy number and arteminisin derivatives combination therapy failure in falciparum malaria in Cambodia

Malaria Journal

Volumn 8, Issue 1, 2009, Pages

  Lim, Pharath ^a   Alker, Alisa P ^b   Khim, Nimol ^a   Shah, Naman K ^b   Incardona, Sandra ^a   Doung, Socheat ^c   Yi, Poravuth ^c   Bouth, Denis Mey ^d   Bouchier, Christiane ^e   Puijalon, Odile Mercereau ^f   Meshnick, Steven R ^b   Wongsrichanalai, Chansuda ^g   Fandeur, Thierry ^f   Le Bras, Jacques ^h   Ringwald, Pascal ^d   Ariey, Frédéric ^a  

^a INSTITUT PASTEUR DU CAMBODGE   (Cambodia)

^b IL   (United States)

^c National Center for Parasitology Entomology and Malaria Control (CNM)   (Cambodia)

^d WORLD HEALTH ORGANIZATION   (Switzerland)

^e INSTITUT PASTEUR   (France)

^f CNRS   (France)

^g Independent Scholar   (Thailand)

^h FACULTÉ DES SCIENCES PHARMACEUTIQUES ET BIOLOGIQUES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMETHER; ARTEMETHER PLUS BENFLUMETOL; ARTESUNATE; BENFLUMETOL; CHLOROQUINE; MEFLOQUINE; MULTIDRUG RESISTANCE PROTEIN 1; QUININE; ANTIMALARIAL AGENT; ARTEMETHER LUMEFANTRINE COMBINATION; ARTEMETHER-LUMEFANTRINE COMBINATION; ARTEMISININ DERIVATIVE; ETHANOLAMINE DERIVATIVE; FLUORENE DERIVATIVE; MDR1 PROTEIN, PLASMODIUM FALCIPARUM; MULTIDRUG RESISTANCE PROTEIN;

ANTIMALARIAL DRUG SUSCEPTIBILITY; ARTICLE; BEDTIME DOSAGE; BLOOD SAMPLING; CAMBODIA; CODON; CONTROLLED STUDY; DNA POLYMORPHISM; DRUG EFFICACY; DRUG TREATMENT FAILURE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MORNING DOSAGE; PLASMODIUM FALCIPARUM; REAL TIME POLYMERASE CHAIN REACTION; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; ADULT; ANIMAL; CHILD; CLINICAL TRIAL; DRUG COMBINATION; DRUG EFFECT; DRUG RESISTANCE; GENE DOSAGE; GENETIC POLYMORPHISM; GENETICS; IC 50; SURVIVAL; THAILAND; TREATMENT FAILURE;

ADULT; ANIMALS; ANTIMALARIALS; ARTEMISININS; CAMBODIA; CHILD; CLINICAL TRIALS AS TOPIC; DRUG COMBINATIONS; DRUG RESISTANCE; ETHANOLAMINES; FLUORENES; GENE DOSAGE; GENETIC VARIATION; HUMANS; INHIBITORY CONCENTRATION 50; MALARIA, FALCIPARUM; MEFLOQUINE; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; PLASMODIUM FALCIPARUM; POLYMORPHISM, GENETIC; SURVIVAL ANALYSIS; THAILAND; TREATMENT FAILURE;

EID: 58449119995     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-8-11     Document Type: Article

References (22)

1. Plasmodium falciparum resistant to chloroquine in Cambodia. DE Eyles CC Hoo M Warren AA Sandosham, Am J Trop Med Hyg 1963 12 840 843 14072437
2. Review of the malaria drug efficacy situation. WHO, World Health Orgnization, Western Pacific Region 2005
3. Development of South-Asia surveillance network for malaria drug resistance. Report on an informal consultative meeting. WHO, World Health Orgnization, Geneva, Switzerland 2002
4. In vitro monitoring of Plasmodium falciparum susceptibility to artesunate, mefloquine, quinine and chloroquine in Cambodia: 2001-2002. P Lim P Chim R Sem S Nemh Y Poravuth C Lim S Seila R Tsuyuoka MB Denis D Socheat F Thierry, Acta Trop 2005 93 31 40 10.1016/j.actatropica.2004.09.002 15589795
5. Pfmdr1 and in vivo resistance to artesunate-mefloquine in falciparum malaria on the Cambodian-Thai border. AP Alker P Lim R Sem NK Shah P Yi DM Bouth R Tsuyuoka JD Maguire T Fandeur F Ariey C Wongsrichanalai SR Meshnick, Am J Trop Med Hyg 2007 76 641 647 17426163
6. pfmdr1 genotyping and in vivo mefloquine resistance on the Thai-Myanmar border. AL Nelson A Purfield P McDaniel N Uthaimongkol N Buathong S Sriwichai RS Miller C Wongsrichanalai SR Meshnick, Am J Trop Med Hyg 2005 72 586 592 15891133
7. Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. RN Price AC Uhlemann A Brockman R McGready E Ashley L Phaipun R Patel K Laing S Looareesuwan NJ White F Nosten S Krishna, Lancet 2004 364 438 447 10.1016/S0140-6736(04)16767-6 15288742
8. Efficacy of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in northwest Cambodia. MB Denis R Tsuyuoka P Lim N Lindegardh P Yi SN Top D Socheat T Fandeur A Annerberg EM Christophel P Ringwald, Trop Med Int Health 2006 11 1800 1807 10.1111/j.1365-3156.2006.01739.x 17176344
9. Surveillance of the efficacy of artesunate and mefloquine combination for the treatment of uncomplicated falciparum malaria in Cambodia. MB Denis R Tsuyuoka Y Poravuth TS Narann S Seila C Lim S Incardona P Lim R Sem D Socheat EM Christophel P Ringwald, Trop Med Int Health 2006 11 1360 1366 10.1111/j.1365-3156.2006.01690.x 16930257
10. Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated falciparum malaria. WHO, (WHO/HTM/RBM/200350) World Health Organization, Geneva 2003
11. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. RE Desjardins CJ Canfield JD Haynes JD Chulay, Antimicrob Agents Chemother 1979 16 710 718 394674
12. Long PCR amplification of Plasmodium falciparum DNA extracted from filter paper blots. N Sakihama T Mitamura A Kaneko T Horii K Tanabe, Exp Parasitol 2001 97 50 54 10.1006/expr.2000.4591 11207114
13. Variations in the sequence and expression of the Plasmodium falciparum chloroquine resistance transporter (Pfcrt) and their relationship to chloroquine resistance in vitro. V Durrand A Berry R Sem P Glaziou J Beaudou T Fandeur, Mol Biochem Parasitol 2004 136 273 285 10.1016/j.molbiopara.2004.03.016 15478806
14. Biased distribution of msp1 and msp2 allelic variants in Plasmodium falciparum populations in Thailand. G Snounou X Zhu N Siripoon W Jarra S Thaithong KN Brown S Viriyakosol, Trans R Soc Trop Med Hyg 1999 93 369 374 10.1016/S0035-9203(99)90120-7 10674079
15. Countrywide survey shows very high prevalence of Plasmodium falciparum multilocus resistance genotypes in Cambodia. N Khim C Bouchier MT Ekala S Incardona P Lim E Legrand R Jambou S Doung OM Puijalon T Fandeur, Antimicrob Agents Chemother 2005 49 3147 3152 16048916 10.1128/AAC.49.8.3147-3152.2005
16. http://www.malaria.mr4.org
17. Real-time quantitative PCR with SYBR Green I detection for estimating copy numbers of nine drug resistance candidate genes in Plasmodium falciparum. ID Ferreira VE Rosario PV Cravo, Malar J 2006 5 1 16420686 10.1186/1475-2875-5-1
18. Chloroquine resistance not linked to mdr-like genes in a Plasmodium falciparum cross. TE Wellems LJ Panton IY Gluzman VE do Rosario RW Gwadz A Walker-Jonah DJ Krogstad, Nature 1990 345 253 255 10.1038/345253a0 1970614
19. Intrahost selection of Plasmodium falciparum pfmdr1 alleles after antimalarial treatment on the northwestern border of Thailand. AC Uhlemann R McGready EA Ashley A Brockman P Singhasivanon S Krishna NJ White F Nosten RN Price, J Infect Dis 2007 195 134 141 10.1086/509809 17152017
20. Resistance to antimalarials in Southeast Asia and genetic polymorphisms in pfmdr1. AL Pickard C Wongsrichanalai A Purfield D Kamwendo K Emery C Zalewski F Kawamoto RS Miller SR Meshnick, Antimicrob Agents Chemother 2003 47 2418 2423 12878499 10.1128/AAC.47.8.2418-2423.2003
21. The pfmdr1 gene is associated with a multidrug-resistant phenotype in Plasmodium falciparum from the western border of Thailand. RN Price C Cassar A Brockman M Duraisingh M van Vugt NJ White F Nosten S Krishna, Antimicrob Agents Chemother 1999 43 2943 2949 10582887
22. Molecular and pharmacological determinants of the therapeutic response to artemether-lumefantrine in multidrug-resistant Plasmodium falciparum malaria. RN Price AC Uhlemann M van Vugt A Brockman R Hutagalung S Nair D Nash P Singhasivanon TJ Anderson S Krishna NJ White F Nosten, Clin Infect Dis 2006 42 1570 1577 10.1086/503423 16652314